References
- Sanders L. Perplexing pain. N Y Times Mag 2009; Nov 1: 24-26
- Albers JW, Fink JK. Porphyric neuropathy. Muscle Nerve 2004;30:410-22
- Shigeru S. Modern diagnosis and management of the porphyrias. Br J Haematol 2006;135:281-92
- Jose J, Saravu K, Shastry BA, Jimmy B. Drug use in porphyria: a therapeutic dilemma. Singapore Med J 2008;49:e272
- Tao YC, Niu DM, Chen JT, et al. Gabapentin reduces neurovisceral pain of porphyria. Acta Neurol Taiwan 2010;19:112-15
- Hsuy H, Gouya L, Deybach JC. Porphyrias. Lancet 2010;375:924-37
- Herrick AL, McColl KE. Acute intermittent porphyria. Best Pract Res Clin Gastroenterol 2005;19:235-49
- Dombeck TA, Satonik RC. The porphyrias. Emerg Med Clin North Am 2005;23:885-9
- Pischik E, Kauppinen R. Neurological manifestations of acute intermittent porphyria. Cell Mol Biol 2009;55:72-83
- Chemmanur AT, Bonkovsky HL. Hepatic porphyrias: diagnosis and management. Clin Liver Dis 2004;8:807-38
- Ferrari AP, Ardengh JC. Endosonography-guided celiac plexus neurolysis in the treatment of pain secondary to acute intermittent porphyria. Endoscopy 2002;34:341-2
- Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-9
- Balwani M, Desnick RJ. The porphyrias: advances in diagnosis and treatment. Blood 2012;120:4496-504
- Wickberg A, Andersson C, Lithner F. Signs of neuropathy in the lower legs and feet of patients with acute intermittent porphyria. J Intern Med 2000;248:27-32
- Cieh CH, Tsai HH, Lu TH, et al. Acute intermittent porphyria with peripheral neuropathy complicated by small-fiber neuropathy. Neuropathology 2007;27:133-8
- Lithner F. Could attacks of abdominal pain in cases of acute intermittent porphyria be due to intestinal angina? J Intern Med 2000;247:407-9
- Morales Ortega X, Wolf Fernandez C, Leal Ibarra T, et al. Porphyric crisis: experience with 30 attacks [in Spanish]. Medicina (Buenos Aires) 1999;59:23-7
- Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 2005;142:439450
- Pierach CA. Porphyrias. In: Bope TP, Kellerman RD, eds. Conn’s Current Therapy. Philadelphia: Elsevier Saunders, 2013. p. 851-854
- Badminton MN, Elder GH. Management of acute and cutaneous porphyrias. Int J Clin Pract 2002;56:272-8
- Johansson A, Nowak G, Moller C. Non-viral delivery of the porphobilinogen deaminase cDNA into a mouse model of acute intermittent porphyria. Mol Genet Metab 2004:82:20-6
- Stein PE, Badminton MN, Barth JH, et al. Lesson of the month. Clin Med 2012;12:293-4
- European Porphyria Network. European porphyria initiative (updated 2012). Available at: http://www.porphyria-europe.com/02-for-healthcare/treatment.asp [Last accessed 13 June 2013]
- Seth AK, Badminton MN, Mirza D, et al. Liver transplantation for porphyria: who, when and how? Liver Transpl 2007;13:1219-27
- Soonawalla ZF, Orug T, Badminton MN. Liver transplantation as a cure for acute intermittent porphyria. Lancet 2004;363:705-6
- Lambrecht RW, Gildemeister OS, Williams A, et al. Effects of selected antihypertensives and analgesics on hepatic porphyrin accumulation. Biochem Pharmacol 1999;58:887-96
- Jensen NF, Fiddler DS, Striepe V. Anesthetic considerations in porphyrias. Anesth Analg 1995;80:591-9
- Rigal JC, Blanloeil Y. Anaesthesia and porphyria. Minerva Anestesiol 2002;68:326-31
- Wu MT, Wu TY, Tai YT, et al. A pharmacist project to reduce meperidine use in surgical patients. J Exp Clin Med 2012;4:245-8
- Latta KS, Ginsberg B, Barkin RL. Meperidine: a critical review. Am J Ther 2002;9:53-68
- Muehlenberg K, Nauck F. Patient controlled analgesia with pethidine in acute intermittent porphyria. Dtsch Med Wochenschr 1995;120:1454
- McNeill MJ, Bennet A. Use of regional anesthesia in a patient with acute porphyria. Br J Anesth 1990;64:371-3
- Bosch L, Villar T, Latorre MY, Pacreu S. Femoral and Sciatic nerve block for knee arthroscopy in a patient with acute intermittent porphyria. Rev Esp Anestesiol Reanim 2016;63:423-6
- Findley H, Philips A, Cole D, Nair A. Porphyrias: implications for anaesthesia, critical care, and pain medicine. Cont Educ Anaesth Crit Care Pain 2012;12:128-33
- Broomfield B. Acute intermittent porphyria treated with chlorpromazine. Proc R Soc Med 1962;55:799-800
- Procter EA, McKenzie IP. Opiate dependence in acute intermittent porphyria. Ir J Psychol Med 1994;11:133-4
- Day RS, Blekkenhorst GH, Eales L. Drug Induced acute porphyric episodes in rats. Int J Biochem 1980;12:1007-11
- Restrepo-Garces C, Gaviria G, Severiche E, Botero-Posada L. Pain management in acute intermittent porphyria: the role of gabapentin. Reg Anesth Pain Med 2008;33:218
- Silvay G, Miller R, Tausk C. Safety of ketamine in patients with acute intermittent porphyria. Case reports. Acta Anaesthesiol Scand 1979;23:329-30
- Kambak M. Ketamine in porphyria. Anesth Analg 1997;84:1395
- Lambrecht RW, Gildemeister OS, Williams A, et al. Effects of antidepressants and benzodiazepine-type anxiolytic agents on hepatic porphyrin accumulation in primary cultures of chick embryo liver cells. J Pharmacol Exp Ther 1999;291:1150-5
- Pimstone NR, Anderson KE, Freilich BL. Acute porphyrias: emergency room recommendations. Available at: http://www.porphyriafoundation.com/for-healthcare-professionals/emergency-guidelines-for-acute-porphyria [Last accessed June 2013]
- Pischik E, Bulyanitsa A, Kazakov V, Kauppinen R. Clinical features predictive of a poor prognosis in acute porphyria. J Neurol 2004;251:1538-41